A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients.

Part of paid clinical trials in Detroit, Michigan.

Sponsor
Barbara Ann Karmanos Cancer Institute
Study ID
NCT07095114
Status
Recruiting
Apply to this trial

Conditions

  • Ductal Carcinoma in Situ
  • Stage I Breast Cancer
  • Stage II Breast Cancer
  • Stage III Breast Cancer

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Magic Ink — OTHER
    A novel ink that is only visible when exposed to Ultraviolet light and can be hidden using white light will be inserted into the dermis to tattoo a radiation guidance tattoo into the skin of the participant

Study Details

The goal of this clinical trial is to learn if tattoos applied with Magic Ink is as safe as commercially available standard tattoo ink for the purpose of radiation in women with breast cancer undergoing radiation treatment. The main questions are: * Is the Magic Ink as safe as standard tattoo ink * Does Magic Ink continue to function and remain visible for radiation therapists during the treatment Participants will be consented and given a skin assessment. Once enrolled participants will be administered the Magic Ink tattoo instead of the standard tattoo ink in preparation for their radiation treatment. Participants will also complete a survey regarding body image. Skin assessment will occur again after the first week of radiation and at 3 months later. Throughout the radiation therapy the medical physicist will complete surveys about ease of set-up of the equipment.

Key Dates

Start date
Aug 18, 2025
Status verified
Sep 2025
Primary completion
Aug 8, 2026
Completion
Aug 8, 2026

Study Design

Enrollment
30 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Magic Ink tattoo
    Magic Ink tattoo ink which is only visible when exposed to ultraviolet light will be used to mark radiation guidance

Primary Outcome Measure

Safety of Magic Ink [ Time Frame: 3 months after completion of Radiation Therapy ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Karmanos Cancer InstituteDetroitMichigan48201
Michael Dominello, DO
[email protected]
313-576-9546

Find similar trials in Detroit, MI

By research site
Karmanos Cancer Institute· Detroit, MI

Related Studies